C15ORF38 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.267200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.421600E-01
Normal-vs-Stage2
9.176600E-01
Normal-vs-Stage3
4.361600E-01
Normal-vs-Stage4
7.005000E-01
Stage1-vs-Stage2
8.265200E-01
Stage1-vs-Stage3
1.473590E-01
Stage1-vs-Stage4
4.282400E-01
Stage2-vs-Stage3
4.976600E-04
Stage2-vs-Stage4
3.459000E-01
Stage3-vs-Stage4
1.738570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.026800E-01
Normal-vs-AfricanAmerican
6.971600E-01
Normal-vs-Asian
7.031600E-01
Caucasian-vs-AfricanAmerican
2.830600E-01
Caucasian-vs-Asian
5.717800E-01
AfricanAmerican-vs-Asian
2.955800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.122600E-01
Normal-vs-Female
9.645000E-01
Male-vs-Female
2.108800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.669400E-01
Normal-vs-Age(41-60Yrs)
8.441600E-01
Normal-vs-Age(61-80Yrs)
6.758200E-01
Normal-vs-Age(81-100Yrs)
4.760400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.883400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.198600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.778200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.881800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.083600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.079400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.548400E-01
Normal-vs-Daily Drinker
6.512400E-01
Normal-vs-Weekly Drinker
6.772800E-01
Normal-vs-Occasional Drinker
6.558800E-01
Normal-vs-Social Drinker
9.026600E-01
Non Drinker-vs-Daily Drinker
6.487200E-01
Non Drinker-vs-Weekly Drinker
7.965000E-01
Non Drinker-vs-Occasional Drinker
8.019400E-01
Non Drinker-vs-Social Drinker
3.827800E-01
Daily Drinker-vs-Weekly Drinker
8.806600E-01
Daily Drinker-vs-Occasional Drinker
8.404800E-01
Daily Drinker-vs-Social Drinker
2.706600E-01
Weekly Drinker-vs-Occasional Drinker
9.730000E-01
Weekly Drinker-vs-Social Drinker
3.446200E-01
Occasional Drinker-vs-Social Drinker
3.045200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.980600E-01
Normal-vs-Grade 2
2.857000E-01
Normal-vs-Grade 3
1.397040E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.373500E-02
Grade 1-vs-Grade 3
6.963600E-03
Grade 1-vs-Grade 4
5.980600E-01
Grade 2-vs-Grade 3
2.190000E-01
Grade 2-vs-Grade 4
2.857000E-01
Grade 3-vs-Grade 4
1.397040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.834000E-01
Normal-vs-NonDiabetic
7.056200E-01
Diabetic-vs-NonDiabetic
9.714000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.646800E-01
Normal-vs-NoPancreatitis
7.329800E-01
Pancreatitis-vs-NoPancreatitis
4.447000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.795200E-01
Normal-vs-N1
9.715600E-01
N0-vs-N1
7.190000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.798800E-01
Normal-vs-TP53-NonMutant
8.031800E-01
TP53-Mutant-vs-TP53-NonMutant
3.719400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
